Fortis Healthcare Ltd

About Fortis Healthcare Ltd

Fortis Healthcare Ltd. is a leading integrated healthcare delivery service provider in India, primarily engaged in operating a network of hospitals and providing diagnostic services through its subsidiary, SRL Diagnostics. It offers a comprehensive range of medical specialities, catering to both domestic and international patients, holding a significant position in the Indian healthcare market.

Key Financial Ratios of Fortis Healthcare Ltd

• P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Fortis Healthcare Ltd's P/E ratio (TTM) is 300, compared to the industry median of 53.17 and large cap median of 66.99.

• P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Fortis Healthcare Ltd's P/B ratio is 6.98, compared to the industry median of 5.27 and large cap median of 8.05.

• P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Fortis Healthcare Ltd's P/S ratio is 7.55, compared to the industry median of 3.91 and large cap median of 9.56.

• PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Fortis Healthcare Ltd's PEG ratio is 1.15.

• EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Fortis Healthcare Ltd's EV/EBITDA ratio is 33.50.

• Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Fortis Healthcare Ltd's ROE is 10.75%.

• Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Fortis Healthcare Ltd's ROA is 13.06%.

• Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Fortis Healthcare Ltd's ROCE is 13%.

• Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Fortis Healthcare Ltd's operating margin is 22.84%.

• Net Margin: Net margin shows what percentage of revenue converts into final net profit. Fortis Healthcare Ltd's net margin is 11.66%.

• Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Fortis Healthcare Ltd's current ratio is 1.

• Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Fortis Healthcare Ltd's debt-to-equity ratio is 0.30.

• Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Fortis Healthcare Ltd's interest coverage ratio is 5.35.

• Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Fortis Healthcare Ltd's DPS is ₹0.97.

• Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Fortis Healthcare Ltd's EPS is 34.50.

(Source line: "Ratios as of 21 Sept 2026, based on last traded price of ₹915. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")

Key Facts

• Founded: 1996

• Headquarters: Gurugram, Haryana

• Core Offerings: Hospital Services, Diagnostic Services, Medical Research, Medical Education, International Patient Services

• Stock Listing: NSE (FORTIS), BSE (532843)

• Promoter: IHH Healthcare Berhad

History of Fortis Healthcare Ltd

Fortis Healthcare was incorporated in 1996. It rapidly expanded its hospital network through organic growth and acquisitions in the 2000s, becoming publicly listed in 2005. A pivotal moment was the acquisition of SRL Diagnostics in 2010, solidifying its presence in the diagnostic segment. In 2018, IHH Healthcare Berhad acquired a controlling stake in Fortis, becoming the new promoter group. This acquisition followed a period of financial and legal challenges for the previous promoters. Under IHH's management, Fortis has focused on operational efficiencies and strategic growth, while continuing to navigate ongoing legal proceedings related to the past promoter entities and IHH's open offer.

Business Segments and Revenue Mix

• Hospital Services: Operates a comprehensive network of multi-speciality hospitals across India, offering tertiary and quaternary care in areas like cardiology, oncology, orthopedics, neurology, and organ transplantation. Services include in-patient care, out-patient consultations, emergency services, and advanced surgical procedures.

• Diagnostic Services: Provided primarily through its subsidiary, SRL Diagnostics, one of India's largest diagnostic chains. It offers a wide array of pathology and radiology tests, supported by an extensive network of labs and collection centers, catering to both institutional and individual patients.

Key Personnel

Ravi Rajagopal (Chairman, Independent Director) - A veteran with extensive experience in corporate strategy, finance, and governance across various industries. Dr. Ashutosh Raghuvanshi (Managing Director & CEO) - A highly regarded healthcare professional and surgeon, known for his leadership in driving operational excellence and strategic growth in the healthcare sector.

Subsidiaries and Associate Companies

• SRL Limited (formerly SRL Diagnostics Ltd.)

• Fortis Hospitals Limited

• Escorts Heart Institute and Research Centre Limited

• Hiranandani Healthcare Private Limited

Corporate Actions

In 2018, IHH Healthcare Berhad acquired a controlling stake in Fortis Healthcare through a preferential allotment and subsequent open offer. The open offer has been subject to ongoing legal proceedings stemming from a contempt case related to the former promoters, which has impacted the completion of the open offer and delisting from the F&O segment. No major recent bonus or rights issues.

References

1. Fortis Healthcare Ltd. Annual Report FY23
2. Exchange Filings (NSE/BSE)
3. Investor Presentations & Financial Results Announcements
4. Company Website